4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations
    Meeting Abstract

    Janjigian, Y. Y.; Park, B. J.; Kris, M. G.; Miller, V. A.; Riely, G. J.; Zheng, J.; Dycoco, J. P.; Shen, R.; Azzoli, C. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis
    Meeting Abstract

    Ilson, D.; Bains, M.; Rizk, N.; Rusch, V.; Flores, R.; Park, B.; Shah, M.; Kelsen, D.; Miron, B.; Goodman, K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803
    Meeting Abstract

    Fuchs, C.; Ogino, S.; Meyerhardt, J. A.; Irahara, N.; Niedzwiecki, D.; Hollis, D.; Saltz, L. B.; Mayer, R. J.; Bertagnolli, M. M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Diabetes mellitus (DM), serum glucose, and outcome in gastroesophageal (GE) cancer
    Meeting Abstract

    Feilchenfeldt, J. W.; Capanu, M.; Farooki, A.; Sully, D.; Miron, B.; Power, D. G.; Jhawer, M.; Ilson, D. H.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The association of PET response with complete pathological response (CPR) and residual nodal disease (RND) after induction chemoradiotherapy (CRT) and resection of esophageal cancer: A review of 493 cases
    Meeting Abstract

    Barnett, S. A.; Rizk, N. P.; Adusumilli, P. S.; Park, B. J.; Bains, M. S.; Flores, R. M.; Goodman, K. A.; Ilson, D. H.; Akhurst, T. J.; Rusch, V. W.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment
    Meeting Abstract

    Poultsides, G. A.; Servais, E. L.; Saltz, L. B.; Patil, S.; Kemeny, N. E.; Guillem, J. G.; Weiser, M.; Temple, L. K.; Wong, W.; Paty, P. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Intensity-modulated radiotherapy and concurrent chemotherapy for locally advanced and resected pancreatic cancer: Evaluation of toxicity and disease control outcomes
    Meeting Abstract

    Wu, A. J.; Jacks, L. M.; Zhang, Z.; Ho, A. Y.; O'Reilly, E. M.; Kowalski, A. V.; Kim, B. H.; Goodman, K. A.
    International Journal of Radiation Oncology, Biology, Physics (2009)

    Fulltext@MSK | Save
  • Multimodality therapy for esophageal cancer
    Book Section

    Ku, G. Y.; Ilson, D. H.
    In Shields, T. W.; LoCicero, J. 3rd; Reed, C. E.; Feins, R. H. (Eds.) General Thoracic Surgery. 7th ed (2009)

    Fulltext@MSK | Save
  • 100 questions & answers about liver cancer. 2nd ed
    Book Whole

    Abou-Alfa, G. K.; DeMatteo, R. P.
    Jones and Bartlett Publishers (2009)

    Fulltext@MSK | Save
  • Update from the 2009 ASCO Annual Meeting: The treatment of metastatic HER2-positive gastric cancer with chemotherapy and trastuzumab
    Journal Article

    Ilson, D. H.
    ASCO News & Forum (2009)

    Fulltext@MSK | Save